Zydus Cadila’s Covid-19 vaccine developed for children above 12 years is likely to get emergency use approval from drug regulator Drugs Controller General of India (DCGI) in the next few days, sources have said. The vaccine has been tested on adults as well as children above 12 years of age and if the regulatory committee is satisfied with the data, it may be given approval for emergency use, officials said. The regulator’s subject expert committee (SEC) will examine data submitted by Cadila. Officials said that if the approval is given, supply of the vaccine is expected to start by August-September.
#ZydusCadila #DCGI #Vaccine #Coronavirus #Monsoon #Delhi #Chirag Paswan
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
